bioRxiv / medRxivopen access
The quality-failure paradox in extracellular vesicle therapeutics: quantitative benchmarking of 152 clinical trials against CAR-T cell therapies.
health economics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 471401
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.